查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1378767

脈絡膜新生血管市場：2023-2028 年全球產業趨勢、佔有率、規模、成長、機會與預測

Choroidal Neovascularization Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 139 Pages | 商品交期: 2-3個工作天內

價格

概要

2022年，全球脈絡膜新生血管市場規模達到60億美元。展望未來， IMARC Group預計到2028年市場規模將達到95億美元，2022-2028年複合年成長率（CAGR）為8.0%。

脈絡膜新生血管（CNV）是指在眼睛脈絡膜層產生新血管，影響布魯赫膜和視網膜色素上皮（RPE）。其症狀包括脂質滲出、視網膜下血液和液體、中央視力扭曲、波紋和黑點。目前，結合螢光素血管攝影（FA）、吲哚菁綠（ICG）血管攝影和光學相干斷層掃描（OCT）掃描等方法來診斷CNV。根據結果，醫生會開出抗血管內皮生長因子（VEGF）藥物、熱雷射治療和光動力治療（PDT），以防止血管生長。

由於老年性黃斑部病變（ARMD）、眼組織胞漿菌病、病理性近視、血管樣條紋、脈絡膜撕裂以及脈絡膜和視網膜發炎性疾病的盛行率不斷上升，該市場正在經歷成長。此外，越來越多的老年人口更容易受到嚴重健康狀況的影響，這是推動市場成長的另一個關鍵因素。此外，聯合藥物的日益普及，以及長效抗 VEGF 藥物的推出，正在推動全球對 CNV 治療的需求。其他因素，例如改善醫療基礎設施和增加研發 (R&D) 活動投資，也促進了市場的成長。

本報告回答的關鍵問題：

  • 迄今為止，全球脈絡膜新生血管市場表現如何，未來幾年將如何表現？
  • COVID-19 對全球脈絡膜新生血管市場有何影響？
  • 主要區域市場有哪些？
  • 依產品類型分類的市場是怎麼樣的？
  • 根據診斷類型，市場的分類是怎麼樣的？
  • 根據治療類型的市場分類是怎樣的？
  • 基於應用程式的市場區隔是什麼？
  • 產業價值鏈的各個階段是什麼？
  • 該行業的關鍵促進因素和挑戰是什麼？
  • 全球脈絡膜新生血管市場的結構如何？誰是主要參與者？
  • 產業競爭程度如何？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 資料來源
    • 主要資源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球脈絡膜新生血管市場

  • 市場概況
  • 市場業績
  • COVID-19 的影響
  • 市場預測

第 6 章：依產品類型分類的市場區隔

  • 靜脈
    • 市場走向
    • 市場預測
  • 玻璃體內
    • 市場走向
    • 市場預測

第 7 章：按診斷類型分類的市場

  • 螢光血管攝影 (FA)
    • 市場走向
    • 市場預測
  • 吲哚菁綠 (ICG) 血管攝影
    • 市場走向
    • 市場預測
  • 光譜域光學相干斷層掃描 (OCT)
    • 市場走向
    • 市場預測
  • 其他
    • 市場走向
    • 市場預測

第 8 章：按治療類型分類的市場區隔

  • 血管新生抑制劑注射液
    • 市場走向
    • 市場預測
  • 光動力療法
    • 市場走向
    • 市場預測
  • 雷射光凝
    • 市場走向
    • 市場預測
  • 低劑量放射治療
    • 市場走向
    • 市場預測
  • 手術
    • 市場走向
    • 市場預測

第 9 章：按應用分類的市場區隔

  • 極度近視
    • 市場走向
    • 市場預測
  • 惡性近視變性
    • 市場走向
    • 市場預測
  • 與年齡相關的發展
    • 市場走向
    • 市場預測

第 10 章：按地區分類的市場細分

  • 北美洲
    • 美國
      • 市場走向
      • 市場預測
    • 加拿大
      • 市場走向
      • 市場預測
  • 亞太地區
    • 中國
      • 市場走向
      • 市場預測
    • 日本
      • 市場走向
      • 市場預測
    • 印度
      • 市場走向
      • 市場預測
    • 韓國
      • 市場走向
      • 市場預測
    • 澳洲
      • 市場走向
      • 市場預測
    • 印尼
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 歐洲
    • 德國
      • 市場走向
      • 市場預測
    • 法國
      • 市場走向
      • 市場預測
    • 英國
      • 市場走向
      • 市場預測
    • 義大利
      • 市場走向
      • 市場預測
    • 西班牙
      • 市場走向
      • 市場預測
    • 俄羅斯
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場走向
      • 市場預測
    • 墨西哥
      • 市場走向
      • 市場預測
    • 其他
      • 市場走向
      • 市場預測
  • 中東和非洲
    • 市場走向
    • 按國家/地區分類的市場細分
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Bausch Health Companies Inc.
    • Bayer AG
    • Gilead Sciences, Inc.
    • F. Hoffmann-La Roche AG
    • MaaT Pharma
    • Novartis AG
    • Pfizer Inc.
    • Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
    • Regeneron Pharmaceuticals Inc.
    • Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
Product Code: SR112023A2561

Abstract

The global choroidal neovascularization market size reached US$ 6.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 9.5 Billion by 2028, exhibiting a growth rate (CAGR) of 8.0% during 2022-2028.

Choroidal neovascularization (CNV) refers to the creation of new blood vessels in the choroid layer of the eyes affecting the Bruch's membrane and retinal pigment epithelium (RPE). Its symptoms include lipid exudation, subretinal blood and fluid, and distortion, waviness and black spots in the central vision. At present, a combination of procedures, such as fluorescein angiography (FA), indocyanine green (ICG) angiography and optical coherence tomography (OCT) scanning, are utilized for diagnosing CNV. As per the results, doctors then prescribe anti-vascular endothelial growth factor (VEGF) drugs, thermal laser treatment and photodynamic therapy (PDT), to prevent the growth of the blood vessels.

The market is experiencing growth on account of the rising prevalence of age-related macular degeneration (ARMD), ocular histoplasmosis, pathologic myopia, angioid streaks, choroidal tears and inflammatory diseases of the choroid and retina. Moreover, the increasing geriatric population, which is more vulnerable to serious health conditions, is acting as another key factor bolstering the market growth. Furthermore, the growing adoption of combination drugs, along with the introduction of long-lasting anti-VEGF drugs, is propelling the demand for CNV treatments worldwide. Other factors, such as improving healthcare infrastructure and the increasing investments in research and development (R&D) activities, are also contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global choroidal neovascularization market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product type, type of diagnosis, treatment type and application.

Breakup by Product Type:

Intravenous

Intravitreal

Breakup by Type of Diagnosis:

Fluorescein Angiography (FA)

Indocyanine Green (ICG) Angiography

Spectral Domain Optical Coherence Tomography (OCT)

Others

Breakup by Treatment Type:

Angiogenesis Inhibitors Injection

Photodynamic Therapy

Laser photocoagulation

Low-dose Radiation Therapy

Surgery

Breakup by Application:

Extreme Myopia

Malignant Myopic Degeneration

Age-Related Developments

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Bausch Health Companies Inc., Bayer AG, Gilead Sciences, Inc., F. Hoffmann-La Roche AG, MaaT Pharma, Novartis AG, Pfizer Inc., Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited), Regeneron Pharmaceuticals Inc. and Sanwa Kagaku Kenkyusho Co. Ltd. (Suzuken Co. Ltd.).

Key Questions Answered in This Report:

  • How has the global choroidal neovascularization market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global choroidal neovascularization market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the type of diagnosis?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global choroidal neovascularization market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Choroidal Neovascularization Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Intravenous
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Intravitreal
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type of Diagnosis

  • 7.1 Fluorescein Angiography (FA)
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Indocyanine Green (ICG) Angiography
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Spectral Domain Optical Coherence Tomography (OCT)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Treatment Type

  • 8.1 Angiogenesis Inhibitors Injection
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Photodynamic Therapy
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Laser Photocoagulation
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Low-dose Radiation Therapy
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Surgery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Extreme Myopia
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Malignant Myopic Degeneration
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Age-Related Developments
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bausch Health Companies Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Bayer AG
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Gilead Sciences, Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 MaaT Pharma
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Novartis AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Pfizer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Quark Pharmaceuticals Inc. (SBI ALApharma Co., Limited)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Regeneron Pharmaceuticals Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Sanwa Kagaku Kenkyusho Co. Ltd. (SUZUKEN CO., LTD.)
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio

List of Figures

  • Figure 1: Global: Choroidal Neovascularization Market: Major Drivers and Challenges
  • Figure 2: Global: Choroidal Neovascularization Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Choroidal Neovascularization Market: Breakup by Product Type (in %), 2022
  • Figure 4: Global: Choroidal Neovascularization Market: Breakup by Type of Diagnosis (in %), 2022
  • Figure 5: Global: Choroidal Neovascularization Market: Breakup by Treatment Type (in %), 2022
  • Figure 6: Global: Choroidal Neovascularization Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Choroidal Neovascularization Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Choroidal Neovascularization Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 9: Global: Choroidal Neovascularization (Intravenous) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Choroidal Neovascularization (Intravenous) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Choroidal Neovascularization (Intravitreal) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Choroidal Neovascularization (Intravitreal) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Choroidal Neovascularization (Fluorescein Angiography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Choroidal Neovascularization (Fluorescein Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Choroidal Neovascularization (Indocyanine Green Angiography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Choroidal Neovascularization (Spectral Domain Optical Coherence Tomography) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Choroidal Neovascularization (Other Type of Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Choroidal Neovascularization (Angiogenesis Inhibitors Injection) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Choroidal Neovascularization (Photodynamic Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Choroidal Neovascularization (Photodynamic Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Choroidal Neovascularization (Laser photocoagulation) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Choroidal Neovascularization (Laser photocoagulation) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Choroidal Neovascularization (Low-dose Radiation Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Choroidal Neovascularization (Surgery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Choroidal Neovascularization (Surgery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Choroidal Neovascularization (Extreme Myopia) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Choroidal Neovascularization (Extreme Myopia) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Choroidal Neovascularization (Malignant Myopic Degeneration) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Choroidal Neovascularization (Age-Related Developments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Choroidal Neovascularization (Age-Related Developments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia Pacific: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia Pacific: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Choroidal Neovascularization Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Choroidal Neovascularization Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Choroidal Neovascularization Industry: SWOT Analysis
  • Figure 86: Global: Choroidal Neovascularization Industry: Value Chain Analysis
  • Figure 87: Global: Choroidal Neovascularization Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Choroidal Neovascularization Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Choroidal Neovascularization Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Choroidal Neovascularization Market Forecast: Breakup by Type of Diagnosis (in Million US$), 2023-2028
  • Table 4: Global: Choroidal Neovascularization Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 5: Global: Choroidal Neovascularization Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 6: Global: Choroidal Neovascularization Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Choroidal Neovascularization Market Structure
  • Table 8: Global: Choroidal Neovascularization Market: Key Players